Health Management

Jim Beiermann, Danny Irland of Southwestern Health Resources Talk ACO, Next Gen. Programs (Pt. 2)

July 11, 2020

Jim Beiermann, CFO, and Danny Irland, senior vice president of network operations and chief network officer of Southwestern Health Resources discuss their focus of value-based care through ACO and Next Generation Programs within the company with Managed Healthcare Executive Senior Editor, Peter Wehrwein.

TRHC Expands Clinical Services to Include MA Enrolled High-Risk, Special Needs Patients

July 10, 2020

The healthcare tech company will assist health plans in meeting Care for Older Adults requirements.

Jim Beiermann, Danny Irland of Southwestern Health Resources Talk ACO, Next Generation Programs (Pt. 1)

July 10, 2020

Jim Beiermann and Danny Irland, both of Southwestern Health Resources, discuss their focus of value-based care through ACO and Next Generation Programs.

Convergence of Dental, Health Insurance Increases

July 02, 2020

Of the 87% of executives who see convergence already happening, 89% say it is accelerating—up from 21% who said the same in 2018.

CT Scans for Diagnosing COVID-19? Not So Much.

June 23, 2020

Early studies from China suggested that CT scans of the lungs could be used to diagnose the disease. But as PCR tests became available, radiology groups said CT scans should be used more sparingly and in confirmed cases.

Flatiron Health's Bobby Green Outlines Cancer Clinical Trial to Understand Genomic Changes in Tumors (Pt. 4)

June 22, 2020

During the American Society of Clinical Oncology 2020 Annual Meeting, Flatiron Health, Foundation Medicine, and Genentech presented plans for the Prospective Clinico-Genomic study (PCG), a low-interventional pilot that will use a technology-enabled prospective data collection platform to simplify data collection for patients with lung cancer being treated through clinical trials. The idea is collect blood samples using Foundation Medicine’s liquid biopsy assay and analyze the results through Flatiron’s platform, to see if genomic changes can be detected over the course of cancer treatment. Bobby Green, MD, chief medical officer for Flatiron Health, spoke with Managed Healthcare Executive®.

High Hopes for Inclisiran. Will the Third Time be the Charm for PCSK9 Inhibition?

June 22, 2020

The two PCSK9 inhibitors have fallen far short of expectations. Inclisiran, which works by RNA inference, only needs to be injected twice a year. 

4 Ways PBMs are Changing

June 22, 2020

Pharmacy benefit managers are taking steps to be more responsible for the total cost of care and to become more transparent, while adding technology tools to support patients, payers and physicians in a post-COVID-19 world.

What to Expect from CMS’ response to COVID-19

June 19, 2020

As the pandemic enters its fourth month in the U.S., the Center for Medicare and Medicaid Innovation (the Innovation Center) has announced several changes that, on the whole, increase flexibility for program participants.

At-Home Pulse Oximeters: The ‘It’ Gadget of the COVID-19 Outbreak

June 19, 2020

Early detection of low blood oxygen levels may detect ‘silent hypoxia’ seen in some patients with COVID-19. But the American Lung Association advises against buying a pulse oximeter unnecessarily.

x